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Oligomers of the amyloid-b peptide (Ab) play a central role in
the pathogenesis of Alzheimer’s disease and have been sug-
gested to induce neurotoxicity by binding to a plethora of
cell-surface receptors. However, the heterogeneous mixtures of
oligomers of varying sizes and conformations formed by Ab42
have obscured the nature of the oligomeric species that bind
to a given receptor. Here, we have used single-molecule imag-
ing to characterize Ab42 oligomers (oAb42) and to confirm the
controversial interaction of oAb42 with the cellular prion pro-
tein (PrPC) on live neuronal cells. Our results show that, at
nanomolar concentrations, oAb42 interacts with PrPC and that
the species bound to PrPC are predominantly small oligomers
(dimers and trimers). Single-molecule biophysical studies can
thus aid in deciphering the mechanisms that underlie recep-
tor-mediated oAb-induced neurotoxicity, and ultimately facili-
tate the discovery of novel inhibitors of these pathways.
For decades, research on the molecular basis of Alzheimer’s
disease (AD) has focused on the molecular component of the
plaques characteristic of the disease, that is, highly structured,
fibrilized amyloid-b (Ab) peptide species. Although soluble Ab
oligomers (oAb) have now emerged as the key neurotoxins in
AD,[1–3] how exactly they disrupt and impair neuronal function
is still a topic of active research. Alongside the view that toxici-
ty is caused directly by oAb interacting with and inserting into
cell membranes,[4–6] receptor-mediated mechanisms of toxicity
have been suggested; among the numerous putative targets
are the RAGE, NMDA, glutamate, insulin, and human LilrB2 re-
ceptors,[7,8] as well as the cellular prion protein (PrPC).[9] Since
the initial discovery of PrPC as a high-affinity receptor for Ab42,
numerous studies have confirmed the existence of a PrPC–
Ab42 peptide interaction in vitro,[9–13] but have debated its
contribution to the neurotoxicity and memory deficits charac-
teristic of AD.[12–20] As with most of the identified Ab receptors,
PrPC was found to bind oAb with much higher affinity than
monomeric Ab (mAb). However, oAb assemblies typically exist
as heterogeneous mixtures of oligomers of varying sizes and
conformational states, and hence it is still a matter of debate
as to which species within such ensembles interacts with
PrPC.[7,21] Indeed, the lack of methods to characterize oligomeric
species that bind putative receptors presents a major hurdle to
understanding AD, as emphasized by three recent re-
views.[7,22, 23] In this study, we used total internal reflection mi-
croscopy (TIRFM) to address this problem. We characterized
the interaction between endogenous PrPC and oAb42 at the
single-molecule level on the surface of live hippocampal cells,
and investigated whether oligomers of a specific size (or from
a specific preparation) bind preferentially to PrPC.
In order to characterize the composition of oligomeric mix-
tures of Ab42 in solution before addition to hippocampal cells,
we used confocal two-color coincidence detection (cTCCD, Fig-
ure 1A). In this technique, two lasers are focused onto the
same spot, thereby resulting in overlapping diffraction-limited
confocal volumes, which are slowly scanned through a solution
containing diffusing Ab42 monomers and oligomers. In order
to generate dual-labeled species upon oligomerization, we ag-
gregated a mixture of Ab42 peptides tagged at the N terminus
with either HiLyte Fluor 488 or HiLyte Fluor 647. Oligomers are
thus distinguished from monomers by the presence in both
detection channels of simultaneous fluorescent signals, the in-
tensity of which can be used to estimate the oligomerization
order of the dual-labeled species (by comparison with the
signal emitted by singly labeled monomeric species). We and
others have investigated the effect of these labels on the ag-
gregation of Ab(1–40), and showed that HiLyte Fluor 647 does
not affect the kinetics of fibril formation and that neither label
affects the rate of monomer consumption during aggregation,
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or the morphology of the resulting fibrils.[24, 25] We have previ-
ously validated the cTCCD method for the study of Ab oligo-
merization by showing that time courses of monomer con-
sumption during aggregation measured by cTCCD and by
quantitative western blotting are in good agreement.[24] Be-
cause reconciling the results from experiments using different
preparation methods has been a major challenge in the field
of Ab research,[23] we investigated the effect of the oAb42
preparation method on the oAb42–PrPC interaction by compar-
ing two different Ab42 aggregation protocols. The first in-
volves the extraction of samples from an aggregating mixture
of Ab42 under fibril-forming conditions (“AGG”); we and others
have previously shown this to generate well-defined popula-
tions of oligomeric species.[24,26] The second method requires
incubation of monomeric peptide solutions at low tempera-
tures for long periods (16–24 h) to produce stable preparations
of amyloid-derived diffusible ligands (“ADDL”) and protofibrils,
which have been used in many studies.[9, 10,12,13, 27] We used the
modified protocol for ADDL preparation of Laurn et al.[9] to
allow direct comparison of our results with previous studies.
Although AGG and ADDL protocols use different Ab concentra-
tions in the aggregation step (10 and 40 mm, respectively),
both preparations were diluted to a total peptide concentra-
tion of 25 pm immediately prior to cTCCD measurements, in
order to minimize multiple occupancy of the femtoliter-sized
confocal volumes. cTCCD characterization showed that both
aggregation protocols produce detectable oligomers (1–3% of
the total number of peptide assemblies, or ~8% of total pep-
tide mass; Figure 1B and see Methods section in the Support-
ing Information), with size distributions that did not differ sig-
nificantly.
Having compared the two preparations by cTCCD, we then
turned to a wide-field single-molecule imaging technique,
TIRFM, to study the Ab42–PrPC interaction on live cells (Fig-
ure 2A). We first determined whether the density of Ab42 spe-
cies bound to the surface of live cells depends on the density
of PrPC molecules expressed at the cell surface. For this, we
used neuroblastoma cells (N2a) that expressed two different
levels of PrPC: cells with endogenous expression (“high” ex-
pression) and cells in which PrPC expression had been reduced
by siRNA targeted at PrPC (“low” expression). We rendered PrPC
at the plasma membrane visible for fluorescence microscopy
by addition of the fluorescently labeled anti-PrPC antibody
POM1.[28] Recent work by Sonati et al. showed not only that
this antibody does not compete for the putative binding site
Figure 1. Characterization of AGG and ADDL Ab oligomer preparations by
cTCCD. A) cTCCD experiment. Ab42 monomers labeled with HiLyte Fluor 488
(m488) and 647 (m647), and oAb42 (o, containing both monomer types) dif-
fuse through the confocal volume (left), which is scanned across the sample.
Asynchronous fluorescent signals (events) are recorded in the green and red
channels for oAb42 monomers (synchronous signals are coincident events;
right). B) Oligomeric fractions and size distributions of oAb42 for both prep-
aration methods as determined by cTCCD (25 pm sample concentration). Oli-
gomeric fraction is the number of oAb42 events divided by total events.
From this fraction, the oAb42 concentration in subsequent experiments was
calculated (i.e. , for oligomer preparations of 500 nm total peptide concentra-
tion: 4.92.9 nm (AGG), 13.72.3 nm (ADDL)). Calculated size distribution is
detailed in the Methods section in the Supporting Information. There is no
significant difference in oligomeric distributions between AGG and ADDL
preparations (two sample independent t-test). All values are meanSD,
n=3.
Figure 2. Correlation of Ab42 and PrPC densities in the membranes of living
cells. A) TIRF microscopy of POM1-labeled[28] PrPC and oAb42 in the plasma
membrane. B) Representative images of cells expressing PrPC at “high” (left,
natural) and “low” (right, PrPC knockdown) levels at the cell surface. Scale
bars : 5 mm. Western blots demonstrating a lower total cellular PrPC expres-
sion; multiple bands (arrows) are different glycosylation states of PrPC (38
and 28 kDa; mature PrPC: 27 kDa[29]) ; actin was used as a loading control.
C) Distributions of PrPC expression in cell membranes as assessed by inte-
grated POM1-Alexa Fluor 488 fluorescence intensities. Each distribution is
shown as a box plot (whiskers: 5th and 95th percentiles ; –: maximum
values) and a scatter plot (each point representing a single cell). PrPC expres-
sion is significantly different for the two cell populations (medianhigh=193,
medianlow=53, p=0 (Mann–Whitney U-test) ; nhigh=426, nlow=507). D) Den-
sity of Ab42 species (number/mm2 102) bound to N2a cells expressing high
and low levels of PrPC (500 nm total peptide; ADDL: medianhigh=0.05 and
medianlow=0.02, p(ADDL)=2.210
5, AGGs: medianhigh=0.09 and me-
dianlow=0.02, p(AGG)=4.410
16, Mann–Whitney U-test ; n(ADDL)=165 (high)
and 123 (low); n(AGG)=115 (high) and 196 (low)). Data were pooled from at
least three independent experiments.
 2014 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2014, 15, 2515 – 2521 2516
CHEMBIOCHEM
COMMUNICATIONS www.chembiochem.org
of oAb42, but also that the conformation of the
oAb42 binding domain is unchanged by binding to
POM1.[30] Although the same study identified cytotox-
ic effects elicited by POM1, these occurred on much
longer timescales (weeks) than that of our biophysi-
cal characterization (hours), so we assume that the
oAb42–PrPC interactions observed here were unaf-
fected by the presence of POM1. Qualitative analysis
by western blotting confirmed that PrPC expression
was substantially suppressed by RNAi (Figure 2B),
leading to a ~ fourfold decrease in fluorescence inten-
sity from cells labeled with POM1 (Figure 2C). We in-
cubated N2a cells expressing “high” and “low” PrPC
levels with HiLyte Fluor 647-labeled Ab42, by using
the AGG and ADDL protocols to produce mixtures of
oligomeric and monomeric Ab42, exactly as for
cTCCD except with dilution to a final concentration
of 500 nm (total peptide, equivalent to 5–15 nm oli-
gomer) rather than 25 pm. We then recorded videos
to resolve the spatiotemporal coordinates of individ-
ual fluorescently labeled Ab42 species on the cell sur-
face, and then counted the number of species bound
to cells in these recordings by using single-particle
tracking.[31] This analysis showed that, for both oligo-
mer preparations, the density of Ab42 species at the
surface of N2a cells was decreased 2.5–4.5-fold upon
siRNA knockdown of PrPC expression (Figure 2D),
thus suggesting that the majority of oligomers are
bound to PrPC at endogenous expression levels.
Having established a correlation between the den-
sity of Ab42 species bound to the cell membrane
and cell-surface PrPC levels, we used single-particle
tracking to detect oAb42–PrPC binding at the single-
molecule level. We extracted 2D trajectories for dif-
fusing Ab42 species and PrPC molecules (POM1) from
TIRFM video recordings of cells with “low” PrPC ex-
pression levels ; these cells exhibited sufficiently low
POM1 densities to enable us to confidently connect
corresponding particle images in successive frames
by using a nearest-neighbor algorithm (Figure 3A,
top and middle panels; Supporting Videos 1 and
2).[32,33] We identified PrPC–oAb42 complexes as
POM1 trajectories that spatially and temporally over-
lapped (i.e. colocalized) with the trajectory of an
Ab42 oligomer (Figure 3A, B bottom panels; colocali-
zation criteria and representative trajectories in the
Experimental Section and Figures S1–S3; see also
ref. [34]). Because the diffusion of receptors in the
cell membrane is a stochastic process, the probability
of two unassociated molecules moving on a similar trajectory
(and within a short distance of one another) is very low on typ-
ical timescales (ms) of single-particle tracking. Hence, in con-
trast to bulk colocalization measurements, the number of
chance coincidence events detected is greatly reduced. Never-
theless, we addressed this quantitatively by estimating the
chance overlap of trajectories by repeating the colocalization
analysis after spatial shuffling (i.e. inverting the image axes:
x!y and y!x for one channel), thus enabling correction of all
colocalization measurements for chance coincidence (Table S1).
Prior to investigation of the PrPC–oAb42 complexes, we evalu-
ated the dynamic range for our approach by measuring the
extent of colocalization for a positive control. We recorded
videos resolving the diffusion of dual-labeled PrPC receptors on
N2a cells by incubating them with both Alexa Fluor 647-la-
beled POM1 and Alexa Fluor 488-labeled POM3 (Figure S4);
Figure 3. Characterization of the oligomerization order of Ab42 bound to PrPC and other
membrane components by TIRFM and single-particle tracking. A) Epitopes recognized by
anti-PrPC antibodies (POM antibodies). Laurn et al.[9] have mapped the binding site of
Ab to residues 95–110, so POM1 can be assumed to bind PrPC independent of any Ab
present, whereas POM3 and Ab compete for the same epitope. B) Single-molecule imag-
ing of PrPC and oAb42 diffusing in live cell membranes. From left to right, first row:
phase contrast image of an N2a cell ; the white frame corresponds to the region shown
in the second and third rows; second row: frame taken from a video showing POM1 anti-
body bound PrPC (left) and HiLyte Fluor 647-labeled Ab42 oligomers (right) ; third row:
color overlay of two channels for the frame above, and color overlay of trajectories (scale
bars : 2 mm). Below: expansion of two colocalized trajectories; the shaded regions corre-
spond to the uncertainty of particle localization (scale bar: 100 nm). C) Extent of colocali-
zation of PrPC-binding antibodies and Ab42 oligomers, corrected for chance coincidence;
(p(n.s.)=0.50, p*=0.01, two-sample t-test, unequal variance assumed). Error bars are SEM.
D) Apparent Ab42 oligomer size distributions for species colocalized, or not, with PrPC by
using the fluorescence intensity of the detected Ab42 species as an indicator of oligomer
size (for details see text) ; median(ADDL)=3 (bound) and 2 (unbound), median(AGG)=2
(bound) and 1 (unbound); n(ADDL)=99 (bound) and 174 (unbound), n(AGG)=48 (bound)
and 112 (unbound).
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these antibodies target different epitopes on PrPC and can
therefore simultaneously bind to a single receptor (Figure 3A).
We analyzed the POM1 and POM3 trajectories for their spatio-
temporal coincidence, and found colocalized fractions of
POM1 and POM3 of 0.390.05 and 0.420.03, respectively
(Figure 3C and Table S1). Although theoretically 100% of these
trajectories should be colocalized, experimentally obtained
values are typically much lower for single-molecule measure-
ments due to dissociation of the antibodies and the fact that
some trajectories are not detected because of limited signal
and fluorophore photobleaching and blinking.[34] Confident
that our method was able to detect colocalization at the
single-molecule level, we analyzed the degree of colocalization
for trajectories extracted from videos to resolve the diffusion
of individual POM1-labeled PrPC receptors and oAb42 mole-
cules. We found that approximately 3% of PrPC receptors colo-
calized with oAb42, possibly due to substantial dissociation of
the complexes prior to recording, whereas 172% (AGG) and
152% (ADDL) of all Ab42 oligomers bound to the cell mem-
brane were coincident with the trajectory of a PrPC receptor
(Figure 3C). We note that previous investigations (using differ-
ent cell lines) reported similarly small fractions of PrPC-bound
Ab42 (~38%,[9] <11%),[35] a result of oligomers binding to
other membrane components in addition to PrPC. In the pres-
ence of the competitive antibody POM3, colocalization of
oAb42 with PrPC was reduced approximately fourfold (Fig-
ure 3C). As POM3 recognizes an epitope (Figure 3A)[28] that
overlaps the putative oAb42 binding site of PrPC,[9] this pro-
vides strong support that colocalization is attributable to a spe-
cific molecular interaction between PrPC and Ab42.
In order to establish the oligomerization order of the Ab42
species bound to PrPC and to allow comparison with oligomers
bound to other membrane components, we extracted the fluo-
rescence intensity of each of the detected Ab42 species follow-
ing colocalization classification.[31,36] These fluorescence intensi-
ties were normalized according to the mean step size of pho-
tobleaching traces recorded for monomeric Ab42 (intensity
analysis in the Experimental Section; representative photo-
bleaching traces in Figure S5). This analysis showed the
median size of a bound oligomer to be approximately a trimer
for the ADDL preparation and a dimer for AGG (Figure 3D). It
is noteworthy that the large interquartile range of fluorescence
intensities indicates that some of the PrPC-bound oAb42 spe-
cies were much larger than a dimer (maximum ~35-mer
(ADDL), 20-mer (AGG)).
In summary, this work confirms that there is a specific inter-
action between oAb42 and PrPC at the surface of neuronal
cells and establishes that the majority of PrPC-bound oAb42
species are small oligomers. The size distribution of oAb42 as-
sociated with PrPC therefore reflects that found in the aggre-
gated mixtures incubated with the cells. This observation was
independent of the oAb42 preparation method, thus suggest-
ing that two commonly used protocols yield oligomers of simi-
lar sizes and similar affinities for PrPC. The question of which
sizes of oAb42 interact most strongly with PrPC has so far elicit-
ed contradictory answers: Larson et al. found that endogenous
PrPC extracted from brain tissue is bound exclusively to dimeric
Ab42,[35] whereas Nicoll et al. suggested that much larger spe-
cies bind most avidly.[37] The latter conclusion was based on
the observation that the abundance of Ab nanotubes in aggre-
gating mixtures correlated with increased occupancy of PrPC in
ELISA measurements. However, the different results are not
necessarily inconsistent, given that the appearance of protofi-
brils in an aggregating mixture is accompanied by an increase
in the concentration of small oAb42. This would lead to an
overall increase in binding affinity of the preparation for PrPC,
even if protofibrilar species are not major players in the bind-
ing process. Our data shed further light on this controversy.
We found that Ab42 species bound to PrPC at the cell mem-
brane are indeed predominantly small oligomers (median size
estimated to be dimers to trimers), but we also observed bind-
ing of oAb42 species with sizes up to 35-mers (i.e. , protofibrilar
oAb42).[38,39] With the caveat that the requirement for removal
of excess oAb42 means that our single-molecule imaging was
not carried out at equilibrium, our data support a scenario in
which the majority of PrPC-bound Ab42s on neuronal mem-
branes are small oligomers, with only a minor contribution
from protofibrils. Single-molecule biophysical studies of the
type described here thus constitute a useful tool to character-
ize the Ab species that interact with specific receptors, without
the need for isolation or stabilization of species of a specific
size.
Experimental Section
Cell culture : Neuroblastoma 2a cells (N2a, ECACC 89121404) were
cultured in DMEM (Invitrogen/Life Technologies) supplemented
with fetal calf serum (10%, FCS; Sigma–Aldrich) and penicillin/
streptomycin (1%) in 5% CO2 at 37 8C.
RNA interference : ON-TARGETplus SMART pool siRNA containing
four siRNA sequences designed to target mouse PrP (Dharmacon/
Thermo Scientific) was used for PrP knockdown, with DharmaFECT
D1 (Dharmacon/Thermo Scientific) as the cellular transfection re-
agent. Prior to the transfection, N2a cells were seeded in six-well
NUNC plates (200000 cells per well). A stock solution of siRNA
(200 mm in RNase-free water) was incubated at 25 8C for 5–10 min;
the RNA concentration was determined by absorbance at 260 nm.
In order to perform the knockdown, the siRNA stock was diluted
100-fold in Gibco Opti-MEM medium (Life Technologies) and mixed
(5 mL) with transfection reagent (30 mL). This mixture was incubated
for 20 min at 25 8C before diluting twofold in DMEM and addition
to the plated cells. The final concentration of siRNA in each well
was 500 nm, and the cells were incubated for a further 48 h at
37 8C prior to sample preparation for imaging. Immunoblotting
was used to confirm that PrPC expression was indeed reduced in
the N2a cells after incubation with siRNA.
Preparation of Ab42 (AGG) oligomers : Monomeric solutions of
Ab42 singly labeled with either HiLyte Fluor 488 or HiLyte Fluor
647 were obtained by dissolving each lyophilized peptide (AS-
60479-01 or AS-64161, Anaspec, Fremont, CA) in NaOH (0.01m)
and sonication on ice for 30 min (Sonorex; Bandelin, Berlin, Germa-
ny).[26] Aliquots of the peptide solutions were flash frozen and
stored at 80 8C. The concentration of each labeled peptide was
measured by using confocal single-molecule spectroscopy as de-
scribed previously.[24] Prior to each aggregation, the peptide solu-
tions were brought to pH 7.4 by diluting to 10 mm in SSPE buffer
 2014 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2014, 15, 2515 – 2521 2518
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(sodium phosphate (10 mm, pH 7.4) with NaCl (150 mm) and
Na2EDTA (10 mm)). Oligomers were prepared by incubating these
solutions for 1 h at 37 8C. For characterization by cTCCD, equimolar
mixtures of HiLyte Fluor 488- and 647-labeled peptide were aggre-
gated and diluted (25 pm total peptide) directly before measure-
ment, as previously described.[24] For characterization of oAb42–
PrPC interactions by TIRFM, Ab42 labeled solely with HiLyte Fluor
647 was aggregated and diluted (500 nm total peptide) before
adding to N2a cells. Although we used different peptide concen-
trations for cTCCD and TIRFM, previous work has shown that the
oligomers are stable over the time taken for the measurements,[24]
so we assume the same oligomer size distributions are present in
both types of experiment.
Preparation of Ab42 (ADDL) oligomers : Ab42 (ADDL) oligomers
were prepared by using the protocol described by Laurn and co-
workers[9] with minor modifications: peptides were singly labeled
with either HiLyte Fluor 488 or HiLyte Fluor 647 instead of biotin,
and the aggregation concentration was 40 instead of 100 mm, as
low yields were obtained from the starting material. As for the
AGG preparation, equimolar mixtures of HiLyte Fluor 488- and 647-
labeled peptides were aggregated and diluted to 25 pm directly
before characterization by cTCCD; Ab42 labeled solely with HiLyte
Fluor 647 was aggregated and diluted to 500 nm before adding to
N2a cells.
Sample preparation for imaging : N2a cells were seeded in Nun-
clon Delta-treated six-well plates (Thermo Scientific) 48 h prior to
experiments, and treated with siRNA as described above if re-
quired. Before imaging, cells were incubated with sterile PBS
(12 min, 37 8C) to ease detachment from the surface by aspirating
with a pipette. Cells (~106) were suspended in DMEM and incubat-
ed in a microcentrifuge tube with solutions of oligomeric Ab42
(prepared as described above; final concentrations as in the text)
and either POM 1 (5 nm) or POM 3 antibodies (1 nm) for 30 min at
4 8C. Cells were then washed with DMEM (3) and PBS (1) with
centrifugation (600g, 2 min) and resuspension of the pellet, and
transferred to glass cover slips for imaging. Cover slips were
cleaned with Piranha solution (sulfuric acid/hydrogen peroxide,
3:1) as described previously,[31] thoroughly rinsed with ultrapure
water (MilliQ, 18.2 MW), exposed to oxygen plasma for 2 min
(Femto Plasma Cleaner; Diener Electronic, Royal Oak, MI, USA), and
subsequently coated with a solution of PLL(20)-g[3.7]-PEG(2.3)/
PEG(3.4)-RGD (12%) (PLL-PEG-RGD, 1 mgmL1; SuSoS AG, Dben-
dorf, Switzerland) for 10 min at room temperature.[31] The slides
were transferred to the microscope stage, cells were added and al-
lowed to settle for 5 min, then imaged at room temperature within
20 min of cell attachment.
TIRFM measurements : Imaging was performed by using total in-
ternal reflection fluorescence microscopy (TIRFM). A HeNe laser
(633 nm; 25-LHP-991(230), Melles Griot, Carlsbad, CA) and a diode
laser (488 nm; PC13589, Cyan Scientific, Spectra Physics, Santa
Clara, CA) were directed into a TIRF objective (60 Plan Apo TIRF,
NA 1.45; Nikon) mounted on an Eclipse TE2000-U microscope
(Nikon) parallel to the optical axis and offset in order to achieve
total internal reflection of the beam. The emitted fluorescence was
collected by the same objective and separated from the returning
TIR beam by a dichroic mirror (FF500/646-Di01; Semrock, Roches-
ter, NY). Green and red fluorescence emissions were separated by
a second dichroic mirror and filter sets (585 DXLR, HQ525/50
(green emission), QMax/EM670-750 (red emission); Omega Optical,
Brattleboro, VT) with a Dual-View imaging system (Photometrics,
Tucson, AZ). The fluorescence signals from both channels were si-
multaneously recorded at 70 8C with a Cascade II :512 EMCCD
camera (Photometrics); each color was recorded on separate
halves of the EMCCD chip. Data were acquired at 28.6 frames per
second with Micro-Manager.[40]
Image analysis : Custom-written MATLAB software (R2011b, Math-
Works, Natick, MA) was used to analyze the image data. After
manual selection of the cell area based on bright-field images ac-
quired during the data collection phase, the fluorescence images
corresponding to the selected cells were band-pass filtered to
remove the low-frequency modulated background and high-fre-
quency camera noise typically in our image data. The implemented
filtering algorithm (bpass.m, David G. Grier, University of Chicago)
was converted to MATLAB format by Eric Dufresne (Yale University)
and is freely available online (http://physics.georgetown.edu/
matlab/index.html, accessed Oct 2014). As the endogenous density
of PrPC receptors in the plasma membrane of N2a cells was too
high for reliable detection of individual fluorescent signals, the
mean fluorescence intensity for whole cells was calculated. As the
observed area of the cell membrane was considerably smaller than
the area selected from the bright-field image (20–25%), the mean
intensity value was only calculated from pixels whose intensities
were larger than the sum of the mean intensity and three standard
deviations of the total area selected. For cells expressing “low”
levels of PrPC, individual spots could be resolved, and detection
and sequential linkage of the detected individual receptor posi-
tions in subsequent frames was performed as previously de-
scribed.[31,32] Briefly, from the positions of each particle in each
frame obtained from spot detection, corresponding particles were
linked by using custom-written MATLAB code and an implementa-
tion of the particle-tracking function of Crocker and Grier [33] writ-
ten in Interactive Data Language (IDL; Exelis Visual Information,
Boulder, CO) The mean nearest-neighbor distance between tracked
particles within a recording was 350–500 nm.
Calculation of localization precision : In order to determine the lo-
calization precision of the imaging system, HiLyte Fluor 647-labeled
Ab42 and 488-labeled POM1 solutions were diluted (1 nm in PBS)
and adsorbed onto a cleaned glass cover-slip for imaging. The
data obtained were used to calculate the localization precision by
determining the positions of the fluorescently labeled species as
previously described.[32] Each particle’s central position was plotted
over time, and the standard deviation (representing particle locali-
zation precision) was calculated (Figure S1). This gave similar preci-
sions (s) for each color: 43.821.4 nm (green channel, POM1, n=
96) and 41.215.3 nm (red channel, Ab42, n=1514).
Determination of channel registration for dual-color imaging : A
grid of regularly spaced, ion-beam-etched holes in gold-on-glass
was used to achieve image registration across both emission chan-
nels. The Dual-View optics were adjusted to maximize the overlap
of the grid images in the two channels under bright-field illumina-
tion (95% of the positions were in alignment with a precision of
146 nm; Figure S2).
Determination of coincidence criterion : We obtained the colocali-
zation criterion from the RMS deviations in the positional accura-
cies for green- and red-emitting molecules [Eq. (1)]
smean ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2488þ s2647
q
ð1Þ
Equation (1) with our positional accuracies (calculated above) gave
a value of 60.126.3 nm. Hence, in order to obtain a 95% proba-
bility of colocalization, the distance threshold is 2s (corresponding
to ~120 nm). Adding the value for our image registration accuracy
(see TIRFM Experimental Setup “Determination of channel registra-
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tion” above), gives a colocalization distance value:
scalcd ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð120 nmÞ2localization on precisionþ ð146 nmÞ2image registration
q
¼ 189 nm
ð2Þ
For this work we chose a colocalization distance of 200 nm, in
order to minimize the chance of missing associated molecules.
Calculation of trajectory coincidence : After the trajectories had
been identified, we examined association by applying a nearest-
neighbor distance approach.[34] For each pair of fluorescence trajec-
tories, the distances between their positions in corresponding
frames were calculated; two molecules were considered associated
if their tracked positions remained within 200 nm (colocalization
criterion) for eight or more frames (>0.28 s), thus obtaining
ncolocalized (PrPC,Ab). To examine the contribution of chance coincidence,
we repeated this colocalization analysis for spatially decoupled tra-
jectory pairs; for this, the coordinates of one of the trajectories
was rotated 908 prior to analysis (x!y and y!x), thus obtaining
ncolocalized (PrPC,Ab),chance. The overall coincidence (of Ab42 with PrP
C)
corrected for chance coincidence events was taken to be
fractioncoincidence,PrP ¼
ncolocalizedðPrP,AbÞncolocalizedðPrP,AbÞ,chance
total number of tracksðAbÞncolocalizedðPrP,AbÞ,chance
ð3Þ
This coincidence value was calculated for each data set (from all
events across every video taken); reported values are meanSD
(n3).
Estimation of oligomerization order of Ab42 colocalized with
PrPC : The intensity of each Ab42 trajectory was averaged over mul-
tiple frames before bleaching, that is, before the intensity of the
particle in frame n+1 dropped below 60% the intensity of the
particle in frame n. Oligomer sizes were estimated from the intensi-
ties as described previously by using monomer intensities derived
from the bleaching step size of immobilized Ab42 monomers
under identical illumination conditions.[31]
Statistical methods : All statistical analysis was performed in
Origin 8 (OriginLab Corp., Northampton, MA). To assess differences
between sets of non-normally distributed data sets, Mann–Whitney
U-tests were used; two-sample Student t-tests and one-factor
ANOVA tests were used for small data sets (n<10).
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